nautilus.bio (NAUT) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Nautilus Biotechnology (NAUT) tadqiqot va ishlanmalar (R&D) uskunalari bozoriga yo'naltirilgan B2B proteomika yechimlarini ishlab chiqadi. Uzoq muddatli qarzdorlikning kapitalga nisbati moliyaviy barqarorlikni namoyish etmoqda, bunda 0.19 ushbu ko'rsatkichning yangi qiymatiga aylandi. Hozirgi vaqtda biznes mahsulotlar tijoratlashtirilishidan oldin R&D investitsiyalariga tayanmoqda. Dasturiy ta'minot va reagentlar uchun keng ko'lamli patentlar yangi ishtirokchilar uchun yengib bo'lmas kirish to'sig'ini yaratadi.
Nautilus Biotechnology, Inc. (NAUT) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Nautilus Biotechnology|NAUT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Nautilus Biotechnology Inc|NAUT - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Nautilus Bio|NAUT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Nautilus Biotechnology|Tezkor likvidlik nautilus.bio
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:nautilus.bio, NAUT
Nautilus Biotechnology (NAUT) rivojlanishi proteomika platformasining tijoratlashtirish sur'ati va kapital yetarliligiga bevosita bog'liq. Ushbu ko'rsatkich uzoq muddatli majburiyatlarning kapitalga nisbati o'lchovini belgilab, moliyaviy barqarorlik darajasini aniqlaydi. Joriy uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor bozor shoklari paytida defolt xavfini baholaydi. Ushbu metrikaning pasayishi biznesning xavfsizlik zaxirasi oshganligini anglatadi. Optimal leveraj balansi qarz moliyalashtirishdan keladigan potentsial foydalarning yo'qolishining oldini oladi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|WGS (GeneDx Holdings) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|RARE: Uzoq muddatli qarzning kapitalga nisbati|Beam Tx (BEAM) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SRPT|Uzoq muddatli qarzning kapitalga nisbati twistbioscience.com|Uzoq muddatli qarzning o'z kapitaliga nisbati TXG (10x Genomics)|Uzoq muddatli kreditlarning kapitalga nisbati NTLA|Uzoq muddatli qarzning kapitalga nisbati STOK (Stoke)|Uzoq muddatli qarzdorlikning kapitalga nisbati BioLife (BLFS)|WVE - Uzoq muddatli qarzning o'z kapitaliga nisbati|MAZE: Uzoq muddatli qarzning o'z kapitaliga nisbati|SION (Sionna Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Prime Medicine Inc (PRME) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Taysha|uniQure Pharma (QURE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MGTX (MeiraGTx Holdings plc)|RGNX (regenxbio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SLDB (Solid Biosciences)|Ocugen Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pacific Biosciences of California - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Benitec Corp BNTC|Design Therapeutics (DSGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati rocketpharma.com (RCKT)|Uzoq muddatli qarzning o'z kapitaliga nisbati FDMT|LXEO (Lexeo) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati KRRO|EDIT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SLN (Silence Therapeutics)|PRQR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Codexis Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SGMO (Sangamo Therapeutics Inc.)|Metagenomi, Inc (MGX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi DTIL|Uzoq muddatli qarzning o'z kapitaliga nisbati Generation Bio Co|Uzoq muddatli majburiyatlarning kapitalga nisbati boundlessbio.com BOLD|Uzoq muddatli qarzning o'z kapitaliga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzning o'z kapitaliga nisbati IMNN (imunon.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|Mustang Bio Inc (MBIO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TransCode - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Bionano Genomics, Inc. (BNGO)|APDN (Applied DNA Sciences, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati bluebird bio Inc. (BLUE)|Uzoq muddatli qarzning o'z kapitaliga nisbati ImmunoPrecise Antibodies Ltd|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning kapitalga nisbati OMIC|Uzoq muddatli qarzning kapitalga nisbati regulusrx.com (RGLS)|Syros Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON: Uzoq muddatli qarzning o'z kapitaliga nisbati|Unity Biotechnology, Inc - Uzoq muddatli kreditlarning kapitalga nisbati